Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...

ver descrição completa

Detalhes bibliográficos
Autores principales: Chen, Runzhen, Liu, Chen, Zhou, Peng, Li, Jiannan, Zhou, Jinying, Wang, Ying, Zhao, Xiaoxiao, Chen, Yi, Yan, Shaodi, Song, Li, Zhao, Hanjun, Yan, Hongbing
Formato: Online Artigo Texto
Idioma:English
Publicado em: Frontiers Media S.A. 2022
Assuntos:
Pharmacology
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Registos relacionados